FDA Inspection 1048111 — Cedars-Sinai Medical Center
The FDA completed an inspection of Cedars-Sinai Medical Center on February 27, 2018 in West Hollywood, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 27, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- West Hollywood, CA (United States)